Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04907526 · ClinicalTrials.gov registry record · Phase 1
Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD
A Phase 1 study of Congenital Heart Disease, SRV Dependent, sponsored by Timothy J Nelson, MD, PhD.
- Active
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 6
- Study locations
NCT04907526 is a Phase 1 study of Congenital Heart Disease, SRV Dependent that is active but no longer recruiting, run by Timothy J Nelson, MD, PhD. The registered enrollment target is 30 participants. The trial reports 6 study locations across 6 states.
The verdict
NCT04907526, a Phase 1 study of Congenital Heart Disease, SRV Dependent, is active but no longer recruiting, sponsored by Timothy J Nelson, MD, PhD.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 6
- Study locations
Study Summary
Researchers want to better understand what happens to the heart when the autologous (from one's own body) stem cells are injected directly into muscle of the right side of the heart during the Fontan (Stage III) surgery. They want to see if there are changes in the electrical activity, the structure, and the function of the heart following this stem cell-based therapy. Researchers will compare the results from people who receive the stem cells to the results from people who do not receive the stem cells.
Conditions Studied
Interventions
- BIOLOGICAL Autologous mononuclear cells
Study Locations (6)
Alabama
- University of Alabama Medical Center - Birmingham
California
- Children's Hospital Los Angeles - Los Angeles
Colorado
- Children's Hospital Colorado - Aurora
Minnesota
- Mayo Clinic - Rochester
Oklahoma
- University of Oklahoma Medical Center - Oklahoma City
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2025-08-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04907526
The ClinicalTrials.gov registry entry for NCT04907526 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Timothy J Nelson, MD, PhD, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congenital Heart Disease, SRV Dependent appearing as the primary indexed condition, and to 1 intervention - of which Autologous mononuclear cells is the first listed.
NCT04907526 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Alabama, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT04907526 about?
NCT04907526 is a clinical study titled "Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD". Researchers want to better understand what happens to the heart when the autologous (from one's own body) stem cells are injected directly into muscle of the right side of the heart during the Fontan (Stage III) surgery. They want to see if there are changes in the electrical activity, the structure...
What is the current status of trial NCT04907526?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2021-06-01. Estimated completion is 2025-08-30.
What conditions does trial NCT04907526 study?
This clinical trial studies the following conditions: Congenital Heart Disease, SRV Dependent.
What interventions are being tested in trial NCT04907526?
The interventions under investigation include: Autologous mononuclear cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT04907526?
This trial is sponsored by Timothy J Nelson, MD, PhD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04907526 being conducted?
This trial has 6 study locations across Alabama, California, Colorado, Minnesota, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.